ATTO vs ARDX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ATTO · Attovia Therapeutics$15.27 ▲ 1.80%
ARDX · Ardelyx$2.88 ▼ 3.68%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ATTO -30.3%
- ARDX -41.3%
Head to head
| Metric | ATTO | ARDX |
|---|---|---|
| Price | $15.27 | $2.88 |
| Change today | ▲ 1.80% | ▼ 3.68% |
| Market cap | $697.09M | $723.95M |
| Return, 3 months | -23.0% | -28.0% |
| Return, year to date | – | -50.6% |
| Return, 1 year | – | -48.5% |
| P/E (TTM) | – | – |
| P/B | -4.8 | 4.4 |
| P/E percentile vs own 5y | 75th | 65th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +23.8% |
| Net profit growth (YoY) | -43.3% | +12.4% |
| Gross margin | – | 94.4% |
| Operating margin | -4,232.9% | -7.9% |
| Net margin | -3,910.0% | -12.4% |
| Return on equity | – | -38.6% |
| Analyst target vs. price | +160.3% | +366.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 45 | 37 |
| 30-day volatility | 63.1% | 50.9% |
| Max drawdown, 1 year | -46.3% | -64.0% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ARDX is the largest of the group by market value.
- ARDX keeps the most profit per dollar of sales.
- ARDX has been the calmest stock over the last 30 days.